Celularity Inc. (CELU)

NASDAQ: CELU · Real-Time Price · USD

1.280

-0.110 (-7.91%)

At close: Mar 11, 2026, 4:00 PM EDT

1.240

-0.040 (-3.13%)

After-hours: Mar 11, 2026, 7:54 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Degenerative Disease	48.39M	17.33M	12.46M	15.81M	8.72M
Degenerative Disease Growth	179.24%	39.05%	-21.19%	81.30%	-43.21%
Biobanking	5.14M	5.44M	5.51M	5.52M	5.56M
Biobanking Growth	-5.53%	-1.29%	-0.18%	-0.61%	-4.04%
Cell Therapy	688.00K	-	-	-	-
Total	54.22M	22.77M	17.98M	21.34M	14.28M
Total Growth	138.11%	26.68%	-15.75%	49.43%	-32.48%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	54.22M	22.77M	17.98M	21.34M	14.28M
United States Growth	138.11%	26.68%	-15.75%	49.43%	-32.48%
Total	54.22M	22.77M	17.98M	21.34M	14.28M
Total Growth	138.11%	26.68%	-15.75%	49.43%	-32.48%

Source: S&P Global Market Intelligence.